返回 Agenda
Session Chair(s)
Karin Van Baelen, PHARMD
Head, Global Regulatory Affairs
Janssen, Belgium
Speaker(s)
Is Our Regulatory System Effective? Recent Examples of Applied Regulatory Science
Hugo Hurts
Medicines Evaluation Board (MEB), Netherlands
Chair HMA Brexit Task Force; Executive Director
The Beauty of New Science - What Is Needed to Translate It into Better Outcomes? An Industry Perspective
Richard Bergström, MS
European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Director General
How Does the Regulatory and HTA System Keep Pace with New Science? EU Commission Perspectives on the EU Pharmaceutical Framework and HTA Cooperation
Ioana-Raluca Siska, MD, PHD
European Commission, Belgium
Policy Officer, Health Technology Assessment